Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Naproxen vs Celecoxib for Arthritis Treatment

Efficacy and Safety Considerations

  • The American College of Rheumatology recommends against designating any particular NSAID as preferred based on efficacy alone for Ankylosing Spondylitis, as head-to-head trials demonstrate no efficacy differences between celecoxib and naproxen for pain or stiffness 1, 2, 3

Clinical Decision Making

  • For patients without contraindications, particularly those with GI risk factors, the American College of Rheumatology suggests considering celecoxib 100 mg twice daily, as it has demonstrated non-inferiority to naproxen in terms of cardiovascular safety 3
  • Naproxen 375-500 mg twice daily may be considered when celecoxib is contraindicated, such as in cases of sulfonamide allergy, or when cost considerations are paramount and the patient has no GI risk factors 3, 4